Hoon Ryu, PhD

Adjunct Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Hoon Ryu earned his doctoral degree from Chonbuk National University, South Korea. He completed a postdoctoral research fellowship and was appointed Instructor of Neurology at Beth Israel Deaconess Medical Center and Harvard Medical School in 1999. He joined the Chobanian and Avedisian School of Medicine’s Department of Neurology in 2004 as an Assistant Professor. Now he is an Associate Professor and an investigator with the Boston University Alzheimer’s Disease Center and VA Boston Healthcare System. He is a director of the laboratory for Neuronal Gene Regulation and Epigenetics. He works on the identification of biomarkers, the determination of molecular genetic, epigenetic mechanisms, and the development of therapeutics using cell culture systems and animal models of neurodegeneration. He has published over 70 original reports.

Research Interests:

Epigenetic changes encompass an array of molecular modifications including DNA methylation and changes to the chromatin packaging of DNA by post-translational histone modifications. The structure, dynamics, and chemical properties of chromatin almost completely determines how, when, and which genes are turned on and off. Chromatin remodeling and transcription regulation are tightly controlled under physiological conditions. Deregulation of chromatin remodeling is linked to the pathogenesis of neurodegenerative disorders but the mechanism is elusive. In order to identify how genomes are deregulated by heterochromatin, Dr. Ryu is performing ChIP genome-wide sequencing combined with RNA-sequencing followed by platform integration analysis. He has found that altered chromatin plasticity is closely linked to the pathogenesis of Huntington’s disease via an expression of ESET (ERG-associated protein with a SET domain), a histone H3K9-specific methyltransferase. Currently, he is conducting research about mechanisms of ESET gene induction and neuronal heterochromatin condensation in Alzheimer’s disease.

Publications

  • Published 10/7/2026

    Kang BG, Han H, Ahn J, Jang M, Ryu HG, Lee HC, Jeong CW, Jung D, Seong SB, Yoon S. Generating interpretable context-aware medical concept embedding implicating expert knowledge using LLMs. Artif Intell Med. 2026 Oct 07; 183:103543. PMID: 42874282.

    Read at: PubMed

  • Published 8/18/2026

    Yang HL, Park SA, Lee H, Jung CW, Ryu HG, Lee HC. Development and validation of a deep learning-based model for estimating stroke volume and blood pressures simultaneously using electrocardiogram and photoplethysmogram. Digit Health. 2026; 12:20552076261479434. PMID: 42620791.

    Read at: PubMed

  • Published 8/1/2026

    Lee S, Kim SC, Noh J, Seo G, Bae Y, Kim SR, Yeon Y, Lee SE, Ha CM, Chang S, Lee J, Ryu H, Park JY, Hwang EM. Mosapride promotes internalization of a TREK1-HTR4 complex and exerts rapid antidepressant-like effects. Mol Psychiatry. 2026 Aug 01. PMID: 42542439.

    Read at: PubMed

  • Published 7/15/2026

    Hyeon SJ, Kim SC, Chu J, Kim Y, Kim C, Park U, Tufail Z, Thi Thanh Nguyen P, Eom A, Kim S, Kim Y, Lee E, Kim S, Lee SE, Woo J, Lee JA, Lee KE, Stein TD, Lee H, Lee J, Ryu H. Targeting the microglial phosphatidylethanolamine synthesis pathway promotes GABARAP-associated phagocytosis and Aß clearance in Alzheimer's disease. Signal Transduct Target Ther. 2026 Jul 15; 11(1). PMID: 42457676.

    Read at: PubMed

  • Published 6/26/2026

    Hwang E, Shim HS, Kim SC, Nam MH, Hyeon SJ, Kim HJ, Kim JE, Park HJ, Woo J, Hwang EM, Stein T, Lee J, Choi JH, Ryu H. Basal forebrain parvalbumin neuron dysfunction links network oscillation deficits to hippocampal pathology in Alzheimer's disease. Res Sq. 2026 Jun 26. PMID: 42396515.

    Read at: PubMed

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research
    Boston University

Websites

Education

  • Chonbuk National University, PhD
  • Chonbuk National University, MS
  • Chonbuk National University, BS